Browsing by Author Pernas, Sònia
Showing results 16 to 22 of 22
< previous
| Issue Date | Title | Author(s) |
|---|---|---|
| 30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
| 21-Nov-2019 | Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center | Sirven, Milana Bergamino; Fernández Ortega, Adela; Stradella, Agostina; Morilla, Idoia; Falo, Catalina; Vázquez, Silvia; Castany, Roser; Villanueva, Rafael; Recalde, Sabela; Navarro Pérez, Valentí; Gil Gil, Miguel; Pernas, Sònia |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
| 15-Oct-2021 | Role of sentinel node biopsy in breast cancer: a review | Pla Farnós, Maria Jesús; Fernández Montolí, Maria Eulalia; Pascal Capdevila, Rosalía; Campos Delgado, Míriam; Bajén Lázaro, Ma. Teresa; Petit Montserrat, Ana; Ortega Martínez, Raul; Martínez Pérez, Evelyn; Pernas, Sònia; Ponce Sebastià, Jordi; García Tejedor, Amparo |
| 23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |
| 24-Apr-2019 | Stratification of cancer and diabetes based on circulating levels of formate and glucose | Pietzke, Matthias; Fernández Arroyo, Salvador; Sumpton, David; Mackay, Gillian M.; Martin Castillo, Begoña; Camps, Jordi; Joven, Jorge; Menendez, Javier A.; Vazquez, Alexei; Pernas, Sònia; Morilla, Idoia; METTEN study group |
| 4-Feb-2020 | Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer | Barroso Sousa, Romualdo; Keenan, Tanya E.; Pernas, Sònia; Exman, Pedro; Jain, Esha; Garrido Castro, Ana C.; Hughes, Melissa; Bychkovsky, Brittany; Umeton, Renato; Files, Janet L.; Lindeman, Neal I.; MacConaill, Laura E.; Hodi, F. Stephen; Krop, Ian E.; Dillon, Deborah; Winer, Eric P.; Wagle, Nikhil; Lin, Nancy U.; Mittendorf, Elizabeth A.; Van Allen, Eliezer M.; Tolaney, Sara M. |